| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
572 |
| issn |
1387-2877
1875-8908 |
| issueIdentifier |
2 |
| pageRange |
567-572 |
| publicationName |
Journal of Alzheimer's disease : JAD |
| startingPage |
567 |
| bibliographicCitation |
Digma LA, Winer JR, Greicius MD. Substantial Doubt Remains about the Efficacy of Anti-Amyloid Antibodies. J Alzheimers Dis. 2024;97(2):567–72. doi: 10.3233/jad-231198. PMID: 38250779. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c248ef21389dfed552b557c875cc3f3f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8dad619a9e8b122ee69a87fb6b65dfc9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_77a8c972773bcc17adbceb70358ed09a |
| date |
2024-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://doi.org/10.3233/jad-231198
https://pubmed.ncbi.nlm.nih.gov/38250779 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1387-2877
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942
https://portal.issn.org/resource/ISSN/1875-8908 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
Substantial Doubt Remains about the Efficacy of Anti-Amyloid Antibodies |
| discusses |
http://id.nlm.nih.gov/mesh/M0556300
http://id.nlm.nih.gov/mesh/M0455693
http://id.nlm.nih.gov/mesh/M000765871 |